Dingzhi Wang

Pharmacology · 2009–2010

A researcher in the Science corpus: 2 papers; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Dingzhi Wang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Harrington
  2. Paul R. Mangan
  3. Bert Vogelstein
  4. C. Weaver

Who trusts Dingzhi Wang overall

  1. Nikos Koundouros
  2. Dingshan Li
  3. G. Poulogiannis

Papers from Dingzhi Wang's perspective

Ordered by how strongly the researchers Dingzhi Wang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. (New England Journal of Medicine)
  2. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. (Cancer Research)
  3. Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis (Science)
  4. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis (Nature)
  5. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. (Blood)
  6. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis (Proceedings of the National Academy of Sciences of the United States of America)
  7. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. (The Lancet Oncology)
  8. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. (Current Opinion in Immunology)
  9. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. (New England Journal of Medicine)
  10. Cancer genes and the pathways they control (Nature Medicine)

Their papers